Sign inJoin waitlistJoin the waitlist

Scott Tykodi

Professor, Clinical Research Division, Fred Hutch · University of Washington School of Medicine

Credentials: · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Hematology and Medical Oncology
University of Washington-Seattle Campus
2000–2003
Internal Medicine
Barnes-Jewish Hospital
1997–2000
Washington University School of Medicine
1993–1997

Research

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
New England Journal of Medicine · 2012 · 6,533 citations
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · 4,745 citations
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised,…
The Lancet Oncology · 2019 · 646 citations

Edus Warren
17 papers
David McDermott
14 papers
JT
John Thompson
14 papers
RM
Robert Motzer
11 papers
Toni Choueiri
11 papers
Saby George
10 papers
Evan Hall
9 papers
Nizar Tannir
8 papers
Shailender Bhatia
8 papers
Shreeram Akilesh
7 papers
Stanley Riddell
7 papers
Elizabeth Plimack
6 papers

Grants

Targeting Novel T Cell Antigens on Renal Cell Carcinoma
National Cancer Institute · K08
Contact PI · $672.2K · Fred Hutchinson Cancer Research Center
2006–2011

Clinical trials

Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer
Principal investigator · Terminated · Phase 1
University of Washington
2018–2022